NCT02457208View on ClinicalTrials.gov

PK Study of Anti-TB Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 7, 2015

Primary Completion Date

January 14, 2018

Study Completion Date

January 14, 2018

Conditions
Tuberculosis
Interventions
DRUG

Isoniazid (H)

DRUG

Rifampicin (R)

DRUG

Pyrazinamide (Z)

DRUG

Ethambutol (E)

Trial Locations (1)

63110

Shoklo Malaria Research Unit, Mae Sot

All Listed Sponsors
lead

University of Oxford

OTHER

NCT02457208 - PK Study of Anti-TB Drugs | Biotech Hunter | Biotech Hunter